Ann: Amended Investor Presentation, page-30

First 30 Last

Share
Profile

Follow
Sharespike

1,545 Posts.

158

21/10/18

12:55

Post #: 36201591
Share

Originally posted by notlistening14 ↑

As I have stated previously -

In Q4FY18 approximately $316k was generated from ohm sales. Relying on the "blended average" sale price of US$750 per month per ohm, we can generate a range of ohms installed for the quarter, being 105-316.

The base case is 105 ohms installed for 3 months generating $316k revenue.
The upper case is 316 ohms installed for 1 month generating $316k revenue.

Practically, it is somewhere in between, although likely to be on the higher side given DM's comment @Send2deking has just shared that an ohm can generate NO revenue in the quarter because of the time when it is installed (this could mean the number is in fact much, much higher - but we simply can't know that until the following quarterly).

In my view, this means based on current information (Note this will be revised following the 31 October quarterly to be released in less than two weeks):

As Q4FY18 revenue was $400k cloud and ~$316k ohm -
Q1FY19 should = $400k cloud + $316k ohm + $316k ohm + any further growth = or ~$1,032m+
Q2Fy19 should = 2xQ1FY19 revenue - $400k = $1,668m+

NOT an exact science. As I have also stated, the more data we have going forward to project Buddy's potential revenue/growth rate, the better.

Note this also doesn't account for Cloud revenue upside, and given Buddy earns a monthly royalty per RV shipped, this number will increase (although again, we don't know by how much).

@Coit would be interested in hearing your thoughts on my reasoning.

Will post a chart later today, Friday was very bullish and given the FA news I think we are going to see a move back up to the 20s sooner than expected (by some, not me)

GLTAH.

Expand

You need to remember that the $316k revenue you reference is AUD. The blended pricing of $750 is USD so has your analysis accounted for this?

Enjoyable read as always

BUD Price at posting: 11.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

1 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BUX

Buxton projects new graphite province discovery at WA Narryer play

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 60 more messages in this thread...

First 30 Last

Add BUD (ASX) to my watchlist

Ann: Amended Investor Presentation, page-30

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News